ALZHEIMER'S INSTITUTE OF AMERICA, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C07K PEPTIDES 1135
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8236346 Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomerOct 03, 08Aug 07, 12[A61K]
8236347 Pharmaceutical compositions for reducing amyloid deposition, amyloid neurotoxicity, and microgliosisFeb 01, 10Aug 07, 12[A61K]
8067372 Modulation of angiogenesis by A-beta peptide fragmentsNov 13, 06Nov 29, 11[A61K, A61P, C07K]
7732467 Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosisMay 17, 04Jun 08, 10[A61K]
7589168 Inhibition of angiogenesis by A-β peptidesAug 12, 02Sep 15, 09[A61K, A01N]
5795963 Amyloid precursor protein in alzheimer's diseaseMar 13, 97Aug 18, 98[C07K]
5455169 Nucleic acids for diagnosing and modeling Alzheimer's diseaseJun 04, 92Oct 03, 95[C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0352,108 AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBK1 AND/OR IKK EPSILONAbandonedDec 23, 14Dec 10, 15[A61K]
2014/0288,044 COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORSAbandonedApr 12, 12Sep 25, 14[C07D]
2010/0130,416 MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTSAbandonedMay 22, 09May 27, 10[A61K, G01N, C07K]
2010/0119,599 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTIONAbandonedDec 10, 07May 13, 10[A61K, A61P]
2010/0093,810 Pharmaceutical Compositions for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and MicrogliosisAbandonedOct 16, 09Apr 15, 10[A61K, A61P]
7605149 Modulation of the phospholipase A2 pathway as a therapeuticExpiredJul 13, 99Oct 20, 09[A61K]
7538258 Transgenic mouse expressing an APP 670/671 mutationExpiredMar 08, 07May 26, 09[A01K, G01N]
2009/0017,112 Compounds for Inhibiting Beta-Amyloid ProductionAbandonedFeb 28, 07Jan 15, 09[A61K, C07D, A61P]
2007/0185,130 Compounds for inhibiting beta-amyloid production and methods of identifying the compoundsAbandonedOct 17, 06Aug 09, 07[A61K, C12Q]
2007/0160,615 Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of Alzheimer's diseaseAbandonedSep 18, 06Jul 12, 07[A61K, C12Q, G01N]
2007/0037,855 Compounds for inhibiting beta-amyloid production and methods of identifying the compoundsAbandonedOct 17, 06Feb 15, 07[A61K, G01N]
2006/0188,938 Compounds for inhibiting beta-amyloid production and methods of identifying the compoundsAbandonedJan 09, 06Aug 24, 06[A61K, G01N]
6818448 Isolated cell comprising HAPP 670/671 DNAS sequencesExpiredFeb 16, 01Nov 16, 04[C12Q, C12N, G01N]
6787318 Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathologyExpiredJun 01, 00Sep 07, 04[G01N]
2003/0077,667 Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's diseaseAbandonedAug 12, 02Apr 24, 03[A61K, G01N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.